Company: VEEAW
Filing Date: 2025-08-14
Form Type: 424B4
Source: 0001213900-25-076086
Chunk: 86

Company: VEEA INC.
Filing Date: 2025-08-14
Form: 424B4
Chunk 86
---
 certain        
 directors and officers; 93,333 shares issued to holders of convertible notes issued by the Company       
 in connection with the Business Combination upon conversion of the notes; 34,184 shares issued to        
 certain employees; and 14,529 issued upon exercise of outstanding stock options for net proceeds         
 of $7.26;                                                                                                |

| ● | on a pro forma as adjusted basis to give further effect to the issuance                                                                  
 and sale of 9,239,096 shares of our common stock and accompanying warrants in this offering, inclusive of the 3,239,096 shares issued    
 to NLabs in full satisfaction and repayment of the 2025 Related Party Notes and reduction of a corresponding amount of debt, at a public 
 offering price of $1.00 per share, after deducting the placement agent fees and estimated offering expenses payable by us, and assuming  
 no exercise of Warrants.                                                                                                                 |

Our capitalization following
the closing of this offering will be adjusted based on the actual public offering price and other terms of this offering determined at
pricing. You should read this table in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results
of Operations” and our financial statements and related notes included elsewhere in this prospectus.

|                                                                                                                                                                                                                                                                                   |     | Actual |              |   |     | Pro Forma |              |   |     | Pro Forma   
 As Adjusted |              |   |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-------|-------------:|:--|:----|:----------|-------------:|:--|:----|:------------|-------------:|:--|
| Cash and cash equivalents                                                                                                                                                                                                                                                         |     | $      |      247,341 |   |     | $         |    1,479,688 |   |     | $           |    6,818,438 |   |
| Current and long-term debt                                                                                                                                                                                                                                                        |     | $      |   14,812,679 |   |     | $         |   18,566,775 |   |     | $           |   15,327,679 |   |
| Stockholders’ equity deficit:                                                                                                                                                                                                                                                     |     |        |              |   |     |           |              |   |     |             |              |   |
| Common stock, par value $0.0001 per share: 551,000,000 shares authorized as of March 31, 2025; 36